EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETES

Jendle, Johan, 1963- (author)

Örebro universitet,Institutionen för medicinska vetenskaper

Edelman, S. (author)

University of California, School of Medicine-Division of Endocrinology and Metabolism, San Diego CA, USA

Dandona, P. (author)

State University of New York, Department of Medicine- Division of Endocrinology- Diabetes and Metabolism, BuffaloNY, USA

show more...

Mathieu, C. (author)

University of Leuven, Clinical and Experimental Endocrinology-UZ Gasthuisberg, Leuven, Belgium

Thoren, F. A. (author)

AstraZeneca, Global Medicines Development, Gothenburg, Sweden

Scheerer, M. F. (author)

AstraZeneca, Diabetes Medical Department, Wedel, Germany

Xu, J. (author)

AstraZeneca, Global Medicines Development, Gaithersburg MD, USA

Langkilde, A. M. (author)

AstraZeneca, Global Medicines Development, Gothenburg, Sweden

show less...

 (creator_code:org_t)

Mary Ann Liebert, 2019

2019

English.

In: Diabetes Technology & Therapeutics. - : Mary Ann Liebert. - 1520-9156 .- 1557-8593. ; 21:Suppl. 1, s. A136-A137

Related links:

https://www.liebertp...

show more...

https://urn.kb.se/re...

https://doi.org/10.1...

https://urn.kb.se/re...

show less...

• Journal article (other academic/artistic)